Molecular Oncology

The Molecular Oncology group, as well as acting as a reference centre for Vall d'Hebron Institute of Oncology’s research programmes, and acting as a central and local laboratory in clinical trials, is also working on its own lines of research. Among its objectives are the discovery and validation of new biomarkers through tissue-based technologies, application of molecular pathology strategies to support initial stage drug development programmes, and definition of the epidemiology of molecular targets to improve personalised treatment strategies.